Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
42.56
-1.09 (-2.50%)
Nov 21, 2024, 4:00 PM EST - Market closed

Avidity Biosciences Statistics

Total Valuation

RNA has a market cap or net worth of $5.08 billion. The enterprise value is $3.63 billion.

Market Cap 5.08B
Enterprise Value 3.63B

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

RNA has 119.31 million shares outstanding. The number of shares has increased by 44.08% in one year.

Current Share Class 119.31M
Shares Outstanding 119.31M
Shares Change (YoY) +44.08%
Shares Change (QoQ) +15.38%
Owned by Insiders (%) 0.41%
Owned by Institutions (%) 87.65%
Float 92.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 238.97
PB Ratio 3.45
P/TBV Ratio 3.41
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 358.49
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.76, with a Debt / Equity ratio of 0.01.

Current Ratio 17.76
Quick Ratio 17.60
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -27.76% and return on invested capital (ROIC) is -19.90%.

Return on Equity (ROE) -27.76%
Return on Assets (ROA) -18.33%
Return on Capital (ROIC) -19.90%
Revenue Per Employee $39,988
Profits Per Employee -$1.11M
Employee Count 253
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +621.44% in the last 52 weeks. The beta is 0.91, so RNA's price volatility has been similar to the market average.

Beta (5Y) 0.91
52-Week Price Change +621.44%
50-Day Moving Average 45.42
200-Day Moving Average 35.00
Relative Strength Index (RSI) 44.89
Average Volume (20 Days) 1,107,147

Short Selling Information

Short Interest 14.66M
Short Previous Month 14.88M
Short % of Shares Out 15.15%
Short % of Float n/a
Short Ratio (days to cover) 17.70

Income Statement

In the last 12 months, RNA had revenue of $10.12 million and -$280.49 million in losses. Loss per share was -$2.85.

Revenue 10.12M
Gross Profit -250.67M
Operating Income -324.69M
Pretax Income -228.68M
Net Income -280.49M
EBITDA -322.04M
EBIT -324.69M
Loss Per Share -$2.85
Full Income Statement

Balance Sheet

The company has $1.59 billion in cash and $7.60 million in debt, giving a net cash position of $1.58 billion or $13.25 per share.

Cash & Cash Equivalents 1.59B
Total Debt 7.60M
Net Cash 1.58B
Net Cash Per Share $13.25
Equity (Book Value) 1.50B
Book Value Per Share 12.64
Working Capital 1.53B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$184.50 million and capital expenditures -$4.01 million, giving a free cash flow of -$188.51 million.

Operating Cash Flow -184.50M
Capital Expenditures -4.01M
Free Cash Flow -188.51M
FCF Per Share -$1.58
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -3,209.34%
Pretax Margin -2,772.44%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -1,322.91%

Dividends & Yields

RNA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -44.08%
Shareholder Yield -44.08%
Earnings Yield -5.46%
FCF Yield -3.67%

Analyst Forecast

The average price target for RNA is $63.22, which is 48.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target $63.22
Price Target Difference 48.54%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 146.17%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RNA has an Altman Z-Score of 10.13 and a Piotroski F-Score of 2.

Altman Z-Score 10.13
Piotroski F-Score 2